Financial News
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
1,051 articles
Memory Chip Shortage Clouds Foxconn Smartphone Unit's Profit Outlook
The smartphone arm of electronics giant Foxconn benefited from increased shipments to a key customer last year, as it reported an annual net profit...
Broadcom Warns Taiwan Semiconductor Capacity Is Maxed Out
On Tuesday, Broadcom Inc. (NASDAQ:AVGO) signaled growing strain in the AI supply chain, warning that limited capacity at Taiwan Semiconductor...
Scott Bessent Rules Out Tax Hikes To Fund Iran War As Costs Climb: 'Why Would We...'
Treasury Secretary Scott Bessent dismissed raising taxes to fund the U.S. military campaign in Iran as "not at all" under consideration, calling the...
📰
FLGT INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Fulgent Genetics Inc.
NEW YORK, March 23, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP continues its investigation on behalf of Fulgent Genetics Inc....
📰
Globus Medical Announces Board Departure
AUDUBON, Pa., March 23, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced...
📰
If You Only Own Tech Stocks, Jim Cramer Has a Blunt Warning for You in 2026
CNBC commentator Jim Cramer sees value in the artificial intelligence (AI) realm beyond the technology sector.
📰
Aardvark Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Voluntary pause of the Phase 3 HERO and OLE trials evaluating ARD-101 for the treatment of hyperphagia in individuals with Prader-Willi Syndrome,...
📰
Aardvark Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
Shareholders that lost money on Picard Medical, Inc.(PMI) should contact Levi & Korsinsky about pending Class Action - PMI
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p>NEW...
📰
Pfizer Stock Is Doing Something It Hasn't Done Since 2022
Up until recently, the stock has been a chronic underperformer.
📰
Levi & Korsinsky, LLP: Fraud-on-the-Market Doctrine Underpins Mereo BioPharma Securities Class Action
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p>NEW...
📰
NKTR Investor Alert: Nektar Therapeutics Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Concealed Trial Protocol Violations: Levi & Korsinsky
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p>NEW...
📰
Levi & Korsinsky, LLP: Rare Stock Loss Quantifies Investor Damages Following Phase III Study Failure Disclosure
NEW YORK, March 23, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP reminds purchasers of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)...
📰
RadNet Insider Sells 15,000 Shares as Stock Falls 12% in 2026
This diagnostic imaging and AI firm disclosed a notable insider sale, as filings highlight steady performance in the healthcare sector.
BlackRock's Larry Fink Warns Of AI Wealth Gap — Are ETFs Fueling Big Tech Dominance?
While the artificial intelligence revolution has propelled markets upward, it might also be contributing to a quiet build of wealth for a few at the...
📰
Shareholders who lost money in shares of Corcept Therapeutics (NASDAQ: CORT) should contact Wolf Haldenstein immediately
NEW YORK, March 23, 2026 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit...
Activist Ubben’s Inclusive Capital Looks to Sell Stake in Bayer
Inclusive Capital Partners is looking to sell a stake in Bayer AG, three years after the investment firm led by activist Jeff Ubben first disclosed a...
📰
Deadline Alert: Nektar Therapeutics (NKTR) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
LOS ANGELES, March 23, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming May 5, 2026 deadline to...
📰
CRISPR Therapeutics Stock: Is It a Bargain Buy Right Now?
The gene-editing stock has been in a tailspin of late.
📰
CRISPR Therapeutics Stock: Is It a Bargain Buy Right Now?
The gene-editing stock has been in a tailspin of late.
Why Are Shares Of Wellgistics Health Falling?
Shares of Wellgistics Health, Inc. (NASDAQ:WGRX) are trading lower after the company announced it entered into non-exclusive, non-binding letter of...
📰
When Insider Selling Is a Good Thing: 2 Stocks to Watch
Ionis Pharmaceuticals and Waste Management insiders sell in early 2026, creating buying opportunities in their stocks while analysts raise price...
Mangoceuticals Stock Doubles After Texas Lawsuit
Mangoceuticals Inc. (NASDAQ:MGRX) shares are surging on Monday. However, there is no news to justify the movement.
The momentum could be due to last...
📰
As Terns Stock Soars 1,400%, What Does One Fund's $5.2 Million Sale Signal to Investors?
This clinical-stage biotech develops therapies for NASH and obesity, advancing a pipeline of proprietary small-molecule drug candidates.
This Box Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades...
This Box Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades...
Michael Burry Says 'Lights Out': Ominous Sign for Stock Market?
Michael Burry's new "Lights Out for Cassandra Unchained" message posted Sunday on X is an ominous signal given his history of going silent just...
📰
INVESTOR DEADLINE: Ultragenyx Pharmaceutical Inc. (RARE) Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - RGRD Law
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p>SAN...
NVO vs. GPCR: Which Obesity Stock is the Better Buy Right Now?
Novo Nordisk faces slowing growth and rising competition, while Structure Therapeutics shows strong obesity study results, highlighting a clash of...
NVO vs. GPCR: Which Obesity Stock is the Better Buy Right Now?
Novo Nordisk faces slowing growth and rising competition, while Structure Therapeutics shows strong obesity study results, highlighting a clash of...